DisorderSİ-FCNCT05295550
Reliability of the Smartphone Inclinometer App and Flexicurve
A study testing Realibility in people with Disorder and Kyphosis Deformity of Thoracic Spine, run by Gaziantep Islam Science and Technology University at 1 site in Turkey (Türkiye).
Trial summary
The presedent study evaluates intra-rater and inter-rater reliability of the Smartphone inclinometer app and the flexicurve, on the thoracic kyphosis Read more about this study
- Who is it for?
- Ages 18 to 30 yearsHealthy volunteers can take part
- Conditions the study is for
- Disorder, Kyphosis Deformity of Thoracic Spine
- What is being tested?
- Realibility
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Sep 2021to 31 Dec 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- over 30 degree toracic kyphosis,
- 18-30 age year old,
- individuals to willing participate in the study
Who cannot join
- Skolyoz (Cobb angle 10< ),
- rigid thoracic kyphosis,
- congenital spine disease,
- training with professional sports
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Hasan Kalyoncu Üniversitesi
Şehitkamil, Gazi̇antep
About this study
Official title: Reliability of the Smartphone Inclinometer Application and Flexicurve on Thoracic Kyphosis
The presedent study evaluates intra-rater and inter-rater reliability of the Smartphone inclinometer app and the flexicurve, on the thoracic kyphosis
Read the detailed description
Sixty subjects ranging from 17to 24 years of age were evaluated by two independent evaluators using the Flexicurve and the Smartphone inclinometer app to measure thoracic kyphosis
- Conditions
- Disorder, Kyphosis Deformity of Thoracic Spine
- Being tested
- Realibility
- Medical subject headings
- Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
RealibilityOther
Also called İntra rater and inter rater
measurement of the thoracic kyphosis with flexicurve and Smartphone inclinometer app
| Study group | Role | What they receive |
|---|---|---|
| Flexicurve-Smartphone İnclinometer Application | Experimental | Measurement of thoracic kyphosis Receives: Other: Realibility |
What is being measured
The primary outcome is the main question the study is designed to answer.
İntra-İnterrater reliability fleksicurve and smartphone inclinometer app on thoracic kyphosis
60 participant (35 male, 25 female) who have over 30 degree thoracic kyphosis were evaluated by two raters for finding correlation between flexicurve and smartphone inclinometer app.
Measured: 1 Year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Mar 2022
- Study start1 Sep 2021
- Primary completion31 Dec 2021
- Study completion31 Dec 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Gaziantep Islam Science and Technology University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Gönül Elpeze, Hasan Kalyoncu University
- Investigators
- GÖNÜL ELPEZE, Principal investigator, HKU
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05295550
- Sponsor's protocol ID
- HKU-GE-SPFC-Realiability
- Acronym
- Sİ-FC
- Status last verified
- Aug 2025
- First submitted
- 3 Mar 2022
- Last updated
- 2 Sep 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Reliability of the Smartphone Inclinometer Application and Flexicurve on Thoracic Kyphosis
- ClinicalTrials.gov ID
- NCT05295550
- Acronym / sponsor ID
- Sİ-FC / HKU-GE-SPFC-Realiability
- Conditions
- Disorder, Kyphosis Deformity of Thoracic Spine
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Gaziantep Islam Science and Technology UniversityUniversity, hospital or other
- Study start
- 1 Sep 2021 (actual)
- Primary completion
- 31 Dec 2021 (actual)
- Study completion
- 31 Dec 2021 (actual)
- First posted
- 25 Mar 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The presedent study evaluates intra-rater and inter-rater reliability of the Smartphone inclinometer app and the flexicurve, on the thoracic kyphosis
Detailed description
Sixty subjects ranging from 17to 24 years of age were evaluated by two independent evaluators using the Flexicurve and the Smartphone inclinometer app to measure thoracic kyphosis
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Flexicurve-Smartphone İnclinometer Application | Experimental | Other: RealibilityMeasurement of thoracic kyphosis |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- over 30 degree toracic kyphosis,
- 18-30 age year old,
- individuals to willing participate in the study
Key exclusion criteria (4 listed)
- Skolyoz (Cobb angle 10< ),
- rigid thoracic kyphosis,
- congenital spine disease,
- training with professional sports
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| RealibilityAlso: İntra rater and inter ratermeasurement of the thoracic kyphosis with flexicurve and Smartphone inclinometer app | Other | Flexicurve-Smartphone İnclinometer Application |
Primary outcome
İntra-İnterrater reliability fleksicurve and smartphone inclinometer app on thoracic kyphosis
Time frame: 1 Year
60 participant (35 male, 25 female) who have over 30 degree thoracic kyphosis were evaluated by two raters for finding correlation between flexicurve and smartphone inclinometer app.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Disorder
Not yet recruitingPhase 2
Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)
Moderate to Severe Psoriatic Arthritis
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
GÖNÜL ELPEZE principal investigator
HKU
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Realibility in people with Disorder and Kyphosis Deformity of Thoracic Spine, run by Gaziantep Islam Science and Technology University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
İntra-İnterrater reliability fleksicurve and smartphone inclinometer app on thoracic kyphosis (time frame: 1 Year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2025.